A detailed history of Abbrea Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Abbrea Capital, LLC holds 11,616 shares of NVS stock, worth $1.28 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
11,616
Previous 11,756 1.19%
Holding current value
$1.28 Million
Previous $1.18 Million 4.74%
% of portfolio
0.16%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$92.57 - $107.37 $12,959 - $15,031
-140 Reduced 1.19%
11,616 $1.24 Million
Q3 2022

Nov 03, 2022

SELL
$74.61 - $87.26 $5,595 - $6,544
-75 Reduced 0.63%
11,756 $894,000
Q4 2020

Jan 21, 2021

BUY
$78.07 - $94.43 $25,841 - $31,256
331 Added 2.88%
11,831 $1.12 Million
Q3 2020

Oct 20, 2020

SELL
$82.14 - $91.0 $17,660 - $19,565
-215 Reduced 1.84%
11,500 $1 Million
Q2 2019

Jul 31, 2019

BUY
$75.4 - $92.8 $883,311 - $1.09 Million
11,715 New
11,715 $1.07 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Abbrea Capital, LLC Portfolio

Follow Abbrea Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.